Insider Trading April 6, 2026

TD Synnex CFO Disposes $611K in Shares as Stock Nears 52-Week High

David Gregory Jordan sold 3,225 shares on April 6, 2026, amid strong quarterly results and analyst upward revisions

By Sofia Navarro SNX
TD Synnex CFO Disposes $611K in Shares as Stock Nears 52-Week High
SNX

TD Synnex Chief Financial Officer David Gregory Jordan sold 3,225 shares of common stock on April 6, 2026, for $189.46 per share, generating proceeds of $611,008. The transaction occurred while the stock traded close to its 52-week peak of $191.78 after a nearly 98% gain over the prior 12 months. Management buybacks and robust fiscal first-quarter results, including an EPS beat and revenue outperformance, have prompted analyst price-target increases.

Key Points

  • CFO David Gregory Jordan sold 3,225 shares on April 6, 2026, for $189.46 per share, totaling $611,008.
  • TD Synnex reported fiscal Q1 2026 EPS of $4.73 versus $3.32 consensus and revenue of $17.16 billion versus $15.59 billion consensus; EPS grew nearly 70% during the quarter.
  • InvestingPro flags the company as undervalued on Fair Value analysis and notes active share buybacks; RBC Capital and Raymond James raised price targets and maintained positive ratings.

TD Synnex (NYSE: SNX) disclosed that Chief Financial Officer David Gregory Jordan sold 3,225 shares of the company's common stock on April 6, 2026, at a sale price of $189.46 per share. The sale produced total proceeds of $611,008 and took place while the stock was trading near its 52-week high of $191.78, following a roughly 98% return over the past year.

After completing the transaction, Jordan retained direct ownership of 14,035 shares of TD Synnex. The insider sale comes amid company-level actions and market data that paint a mixed picture of valuation and capital allocation.

Valuation and capital activity

Data from InvestingPro indicates that TD Synnex remains undervalued on a Fair Value basis and notes that management has been actively repurchasing shares. The stock currently trades at a price-to-earnings ratio of 15.93. InvestingPro additionally lists 16 exclusive tips available for further analysis.

Recent financial performance

TD Synnex reported strong fiscal first-quarter results for 2026, surpassing analyst expectations on both the earnings and revenue fronts. Earnings per share came in at $4.73, compared with the projected $3.32 - a positive surprise of 42.47%. Revenue for the quarter reached $17.16 billion, topping the anticipated $15.59 billion by 10.07%.

During the quarter, earnings per share expanded by nearly 70%, a metric that underpinned positive sentiment among analysts and investors.

Analyst reaction

Following the earnings release, RBC Capital raised its price target on TD Synnex to $210 from $180 and maintained an Outperform rating, citing confidence in the company’s growth prospects. Raymond James also increased its target to $200 from $175 and continued to rate the stock as a Strong Buy, pointing to substantial growth in revenue and profitability metrics.


These developments - the insider share sale, InvestingPro's valuation view and management buybacks, robust quarterly results, and subsequent analyst upgrades - provide a concentrated snapshot of investor and management behavior. While the insider sale represents a notable individual transaction, earnings beats and analyst target increases reflect broader market enthusiasm following the strong quarter.

Note: The factual details in this report reflect the disclosures and analyst actions as stated above.

Risks

  • Insider selling may be viewed negatively by some investors despite other positive indicators - this creates potential short-term perception risk in equity markets.
  • Sustaining the pace of revenue and earnings growth is necessary to justify higher analyst targets; future quarters may change investor sentiment and valuations.
  • Reliance on buybacks as a capital-allocation tool may affect financial flexibility if market conditions or cash generation change.

More from Insider Trading

Lipocine Director Purchases 123,000 Shares Amid Mixed Clinical News Apr 6, 2026 Kinder Morgan Vice President Disposes of $203K in Class P Shares Apr 6, 2026 RA Capital Disposes $14.5M of Vor Biopharma Stock Across Early April Trades Apr 6, 2026 Magnetar Financial Disposes of 23,088 Wheeler Real Estate Shares for About $21.5k Apr 6, 2026 Lipocine CEO Mahesh Patel Buys $50,749 of Stock as Company Reports Phase 3 Setback Apr 6, 2026